RZNOMICS
LIVE

Serial Number

79300505

Owner

Rznomics Inc.

Attorney

Kisuk Lee

Filing Date

Nov 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RZNOMICS Trademark

Serial Number: 79300505 • Registration: 6585436

RZNOMICS is a trademark filed by Rznomics Inc. on November 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Rznomics Inc.

#327, 152, Jukjeon-ro,

Entity Type: 03

Trademark Details

Filing Date

November 13, 2020

Registration Date

December 14, 2021

Published for Opposition

September 28, 2021

Goods & Services

Ophthalmic preparations; pharmaceutical products for the treatment of viral and infectious disease, for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceuticals for the treatment of cancer disease, neurodegenerative disease, neurodevelopmental disorder, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease; pharmaceutical preparations acting on the central nervous system for the treatment of dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuromuscular disorders, neurodevelopmental disorders, neurovascular disease; anti-cancer preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for the use in hematology; anti-diabetic pharmaceuticals; pharmaceutical products for the treatment of infectious disease; anti-dermoinfectives; pharmaceutical preparations for the treatment of kidney disease; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations in the nature of autonomic drugs for medical purposes; pharmaceutical products for treating respiratory disease; pharmaceutical preparations for treating epidermal problems; viral vaccines; anti-viral agents, namely, anti-viral disinfectants; pharmaceutical and veterinary preparations for the treatment of cancer disease, neurodegenerative disease, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease

Research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous disease; scientific research for medical purposes in the area of cancerous disease; research and development in the fields of pharmaceutical and biotechnology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; pharmaceutical products development; research on the subject of pharmaceuticals; clinical studies of medicines, namely, clinical research in the field of cancer therapy, neurodegenerative disease therapy, neurodevelopmental disorder therapy, eye disease therapy, muscular disease therapy, infectious disease therapy, cardiovascular disease therapy, gastrointestinal disease therapy, blood disease therapy, metabolic disease therapy, immune disease therapy, genetic disease therapy, radiology, chemotherapy; medical research services for assessing the efficiency of pharmaceuticals; pharmaceutical drug development services; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medicine research, namely, research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of medical products; providing information on the test, inspection, and research of medical products; consultation and providing information in the fields of pharmacology; industrial research in the fields of medicine, health and pharmacology; analysis of human tissues for medical research

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 21, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 27, 2022 FICS
FINAL DISPOSITION PROCESSED
May 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 14, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 14, 2021 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 12, 2021 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 28, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 28, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 8, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 24, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 24, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 24, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 24, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 24, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 23, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 23, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 23, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 23, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 23, 2021 COAR
REFUSAL PROCESSED BY IB
May 23, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 28, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 28, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 28, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 27, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 2, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 24, 2020 REPR